|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 156 JPY | -4.29% |
|
-2.50% | -36.84% |
SymBio Pharmaceuticals Limited reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was JPY 4,421.1 million compared to JPY 7,355.51 million a year ago. Net loss was JPY 788.71 million compared to net income of JPY 1,555.75 million a year ago.
Basic loss per share from continuing operations was JPY 19.89 compared to basic earnings per share from continuing operations of JPY 40 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -36.84% | 48.22M | |
| +35.01% | 709B | |
| +30.74% | 595B | |
| -2.60% | 367B | |
| +20.83% | 334B | |
| +5.69% | 289B | |
| +14.75% | 239B | |
| +9.52% | 211B | |
| -3.80% | 203B | |
| +10.77% | 171B |
SYMBIO PHARMACEUTICALS LIMITED 
